Cancer Vaccine Institute News

The biggest challenge in ovarian cancer isn’t getting to remission - it’s staying there. Recurrence rates are high, especially for advanced disease. Nineteen-year survivor and CVI vaccine recipient Jamie Crase captures that stark reality: “Stage 4 ovarian cancer has a 90-95% chance of recurrence after the initial treatment. The odds were not in my favor.” At the Cancer Vaccine Institute, we are changing the odds in the favor of Jamie and all patients diagnosed with this deadl

Developing Vaccines to Create a New Standard of Care On October 22, 2025, the Cancer Vaccine Institute (CVI) at UW Medicine welcomed patients, advocates, researchers, and community members to DeLille Cellars in Woodinville, WA for an evening of connection and discovery. “Changing the Course of Ovarian Cancer” highlighted how cancer vaccines, once considered aspirational, are now changing lives and redefining what’s possible in cancer care. Driving a New Standard of Care The e

The Cancer Vaccine Institute is proud to recognize Stephanie N. today! Stephanie was diagnosed with HER2-positive breast cancer in 2000...

Kim was diagnosed with stage IIIC ovarian cancer on September 28, 2009. She had experienced some of the classic symptoms of ovarian...

By Jamie C. My cancer story begins in 2007, when I was a healthy, traveling, living life, family planning 34 year old. I had never been...